Under construction – not a live service
Sign in
Taking peopleNo phase

Ventricular Tachycardia：A Registry Study

Key facts

Who runs it
Beijing Anzhen Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
1,000 people, planned
Started
14 Oct 2025
Expected to end
1 Dec 2029
Type of study
Observational
Treatments tested
  • Standard Clinical Care
Record updated
29 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Adults aged ≥18 years
  • Documented sustained ventricular tachycardia (VT), or nonsustained VT requiring therapeutic intervention in the investigator's judgment, confirmed by a 12-lead electrocardiogram, ambulatory electrocardiographic monitoring, continuous cardiac monitoring, implantable cardiac device recordings, or electrophysiological study
  • Structural heart disease diagnosed according to current clinical guidelines
  • Willing and able to provide written informed consent
  • Willing to comply with the study follow-up schedule

Who cannot take part

  • Cardiac surgery within 60 days before enrollment
  • Ventricular tachycardia secondary to reversible causes (e.g., acute myocardial ischemia or electrolyte disturbances)
  • Idiopathic ventricular tachycardia without evidence of structural heart disease
  • Severe infectious diseases (e.g., septic shock or sepsis)
  • Any other condition that, in the investigator's judgment, makes the participant unsuitable for study participation
  • Severe coagulation disorders, including platelet count <50 × 10⁹/L or disseminated intravascular coagulation
  • Participation in another interventional clinical study that may interfere with this registry

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Structural heart disease-related ventricular tachycardia (SHD-VT) is associated with substantial morbidity and mortality. Although catheter ablation, ICD therapy, antiarrhythmic drugs, and other treatment strategies are widely used, real-world evidence regarding patient characteristics, management patterns, long-term outcomes, and prognostic factors in China remains limited. This nationwide, multicenter, prospective observational registry aims to establish a comprehensive longitudinal database of patients with SHD-VT. Approximately 1,000 consecutive adult patients with documented sustained ventricular tachycardia, or clinically significant nonsustained ventricular tachycardia requiring treatment, in the presence of structural heart disease will be enrolled and followed prospectively. The study will collect detailed demographic characteristics, medical history, imaging findings, laboratory data, electrophysiological characteristics, treatment strategies, and follow-up outcomes without influencing routine clinical management. The primary effectiveness outcome is a composite of ventricular tachycardia recurrence or appropriate ICD therapy (when applicable), unplanned cardiovascular hospitalization, or all-cause death within 12 months. Long-term follow-up will continue to evaluate clinical outcomes, treatment safety, and prognostic factors. The registry is expected to provide high-quality real-world evidence to improve risk stratification, optimize clinical decision-making, and support future clinical research in patients with SHD-VT.

The group in the trial

  • SHD-VT Cohort

    This cohort includes consecutive adult patients with structural heart disease and documented sustained ventricular tachycardia, or clinically significant nonsustained ventricular tachycardia requiring treatment, enrolled in a prospective multicenter observational registry. All treatment decisions are made according to routine clinical practice without study intervention.

    Treatment: Standard Clinical Care

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
29 July 2026